It is astonishing how a pea-sized gland in one’s neck could be so troublesome. Dr. Jesse Pasternak is an endocrine surgeon at Toronto General Hospital. In this episode, we delve into the workup of hyperparathyroidism, Dr. Pasternak’s approach to parathyroid surgery, and his thoughts on the introduction of new surgical techniques. Links:1. Charles Martell (first successful parathyroidectomy): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135504/2. Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. https://pubmed.ncbi.nlm.nih.gov/31623853/3. David Urbach on language around thyroid nodules: https://soundcloud.com/cjs-podcast/e17-david-urbach-on-checklists-wait-times-in-the-time-of-covid-and-medical-devices/reposts4. The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms. https://pubmed.ncbi.nlm.nih.gov/30896738/Bio (https://surgery.utoronto.ca/faculty/jesse-pasternak):Dr Jesse Pasternak is an endocrine surgeon specializing in the surgical management of thyroid, parathyroid and adrenal tumors. After obtaining his undergraduate degree at McGill University, he completed his medical school and residency at McMaster University in Hamilton. He then moved to San Francisco, California where he trained as an Orlo Clark Fellow in Endocrine Surgery and Oncology at UCSF. Dr Pasternak also completed a master’s degree (MPH) at Harvard University with a focus in epidemiology. As a surgeon at the University Health Network, his clinical focus is minimally invasive endocrine surgery. As a researcher, he studies clinical endocrine surgery and health outcomes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related